2021
DOI: 10.1016/j.jaip.2020.10.056
|View full text |Cite
|
Sign up to set email alerts
|

“Omalizumab plus”: Combining omalizumab with immunosuppression for treatment of refractory chronic urticaria: A multicenter UK series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 7 publications
0
0
0
Order By: Relevance